How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?-Reference-Cited by-同舟云学术

How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?

Published:2022-06 Issue:6 Volume:32 Page:6S43-6S53
ISSN:1166-7087
Container-title:Progrès en Urologie
language:en
Short-container-title:Progrès en Urologie

Author:

Baboudjian M.,Gauthé M.,Barret E.,Brureau L.,Rocchi P.,Créhange G.,Dariane C.,Fiard G.,Fromont G.,Beauval J.-B.,Mathieu R.,Renard-Penna R.,Roubaud G.,Ruffion A.,Sargos P.,Rouprêt M.,Ploussard G.

Publisher

Elsevier BV

Subject

Urology

Reference48 articles.

1. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates;Culp;Eur Urol,2020

2. National trends in management of localized prostate cancer: A population based analysis 2004-2013;Chen;Prostate,2018

3. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer;Cornford;Eur Urol,2021

4. Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review;van den Bergh;Eur Urol,2016

5. Management of nonmetastatic castrate-resistant prostate cancer: A systematic review;Loriot;Cancer Treat Rev,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apalutamide for non-metastatic castration-resistant prostate cancer (nmCRPC): real world data of a multicenter study;Journal of Cancer Research and Clinical Oncology;2024-09-09

2. Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments;Cancers;2023-10-19